斯凯(MOBI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MOBI 斯凯

退市 11-17 16:00:00 EST

2.14

+0.00

0.00%

最高2.14	最低2.14	成交量0.00
今开2.14	昨收2.14	日振幅0.00%
总市值6,353万	流通市值3,305万	总股本2,969万
成交额0.00	换手率0.00%	流通股本1,545万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MOBI","market":"US","secType":"STK","nameCN":"斯凯","latestPrice":2.14,"timestamp":1479416400000,"preClose":2.14,"halted":4,"volume":0,"delay":0,"floatShares":15445606,"shares":29687841,"eps":0.18,"marketStatus":"退市","marketStatusCode":7,"change":0,"latestTime":"11-17 16:00:00 EST","open":2.14,"high":2.14,"low":2.14,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.18,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1731920400000},"adr":0,"listingDate":1291957200000,"adjPreClose":2.14,"volumeRatio":0},"requestUrl":"/m/hq/s/MOBI","defaultTab":"news","newsList":[{"id":"2483842197","title":"美股新股前瞻|营收来源单一化 主营产品毛利率降低 斯凯蒙太阳能上市难轻松？","url":"https://stock-news.laohu8.com/highlight/detail?id=2483842197","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483842197?lang=zh_cn&edition=full","pubTime":"2024-11-14 16:27","pubTimestamp":1731572841,"startTime":"0","endTime":"0","summary":"尽管选择赴美上市有很多战略意义，但从业绩表现来看，斯凯蒙太阳能能否赢得投资者信心仍要看其基本面“硬核”与否。就业绩表现来看，斯凯蒙太阳能增利不增收显著。简言之，斯凯蒙太阳能的营收愈发依赖单一的光伏产品，高性能计算服务器销售规模和占比均下滑严重。斯凯蒙太阳能作为中小企业参与者，有望受益于亚洲太阳能光伏市场的增长红利。斯凯蒙太阳能的赴美上市，也是进一步向海外市场布局。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1210861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000591","MOBI"],"gpt_icon":0},{"id":"2482651245","title":"美股新股前瞻|年营收破3.5亿人民币，斯凯蒙(PN.US)在行业低谷期冲刺美股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482651245","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482651245?lang=zh_cn&edition=full","pubTime":"2024-11-11 10:21","pubTimestamp":1731291683,"startTime":"0","endTime":"0","summary":"从业绩来看，斯凯蒙的业务经营或已有回暖之势。数据显示，2023财年时，斯凯蒙的收入下滑约14%至5081.57万美元，期内净利润下滑15.91%至180.77万美元。至2024财年上半年，斯凯蒙的收入同比增长1%至2248.36万美元，期内净利润增长844.56%至64.35万美元，收入、净利润均止跌回升。而斯凯蒙2023财年业绩的下滑便是由于HPC服务器业务拖累所致。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209060.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MOBI"],"gpt_icon":0},{"id":"2481511861","title":"斯凯生物科学公司（Skye Bioscience Inc）公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2481511861","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481511861?lang=zh_cn&edition=full","pubTime":"2024-11-08 13:11","pubTimestamp":1731042708,"startTime":"0","endTime":"0","summary":"斯凯生物科学公司公布截至 9 月 30 日的季度业绩 - 收益摘要Skye Bioscience Inc SKYE.OQ报告了截至9月30日的季度调整后每股亏损10美分。Skye Bioscience Inc报告的季度每股收益为亏损10美分。该公司当季亏损 390 万美元。Skye Bioscience Inc 的股价本季度上涨了 37.3%，今年迄今为止上涨了 97.4%。生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对斯凯生物科学公司 12 个月目标价的中位数为 19.00 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF0M2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MOBI","SKYE"],"gpt_icon":0},{"id":"2481167519","title":"一图解码：斯凯蒙太阳能赴美IPO 聚焦太阳能光伏产品 业绩回升","url":"https://stock-news.laohu8.com/highlight/detail?id=2481167519","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481167519?lang=zh_cn&edition=full","pubTime":"2024-11-08 10:29","pubTimestamp":1731032962,"startTime":"0","endTime":"0","summary":"近日，Skycorp Solar Group Limited（斯凯蒙太阳能集团有限公司，以下简称“斯凯蒙太阳能”）在美国证券交易委员会(SEC)更新了招股书，计划在纳斯达克交易所挂牌上市，股票代码为“PN”。","market":"us","thumbnail":"https://images.finet.hk/photoLib/title/202411_1/2e277eb9-7d6b-490b-bf22-1b028c857be5.jpg","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202411_1/2e277eb9-7d6b-490b-bf22-1b028c857be5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/672d778253243c06d087f409","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["MOBI"],"gpt_icon":0},{"id":"2481646589","title":"斯凯蒙太阳能集团(PN.US)IPO定价4-5美元/股 拟筹资1200万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481646589","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481646589?lang=zh_cn&edition=full","pubTime":"2024-11-06 14:25","pubTimestamp":1730874349,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国太阳能技术供应商斯凯蒙太阳能集团周二向美国证券交易委员会提交了首次公开募股申请。这家总部位于中国宁波的公司计划以每股4美元至5美元的价格发行270万股股票，筹资1200万美元。按拟议发行价区间的中点计算，斯凯蒙太阳能集团的市值将达到1.25亿美元。斯凯蒙太阳能集团成立于2011年，在截至2024年3月31日的12个月里营收为5100万美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1207348.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MOBI","BK0271","BK0132","000591","BK0054"],"gpt_icon":0},{"id":"2481686567","title":"美国一男子被控企图使用大规模杀伤性武器 企图摧毁能源设施","url":"https://stock-news.laohu8.com/highlight/detail?id=2481686567","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481686567?lang=zh_cn&edition=full","pubTime":"2024-11-05 07:58","pubTimestamp":1730764683,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["MOBI","159945"],"gpt_icon":0},{"id":"2479223033","title":"斯凯孚以约 2.16 亿美元的价格剥离美国非核心航空业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2479223033","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479223033?lang=zh_cn&edition=full","pubTime":"2024-10-30 02:09","pubTimestamp":1730225381,"startTime":"0","endTime":"0","summary":"    路透10月29日 - 瑞典斯凯孚公司周二表示，作为退出非核心航空航天领域战略的一部分，该公司通过子公司PCTI将其位于宾夕法尼亚州汉诺威的环形密封件业务以23亿瑞典克朗的价格出售给Carco PRP公司，。斯凯孚在去年 10 月首次透露了探索  全部或部分退出非核心业务的计划。斯凯孚是全球最大的工业轴承生产商，今年7月预计第三季度的同类销售额将持平，并表示低产量和生产转移可能会影响今年下半年的利润率。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MOBI"],"gpt_icon":0},{"id":"2461550314","title":"BUZZ-斯凯生物科学公司因启动肥胖症药物试验而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2461550314","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461550314?lang=zh_cn&edition=full","pubTime":"2024-08-22 20:54","pubTimestamp":1724331284,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    8月22日 - ** 药物开发商Skye Bioscience   股价盘前上涨3.3%至5.67美元** 该公司表示，它已开始为一项中期研究筛选患者，该研究将测试其减轻肥胖症患者体重的实验性药物 ** 基于抗体的药物尼马单抗以调节细胞功能和新陈代谢的大麻素1型受体为靶点** 该研究将评估减轻体重的可持续性参数，包括胃肠道耐受性和瘦体重保持率 -SKYE** SKYE 计划于 2025 年第二季度报告研究的中期数据，并于 2025 年第四季度报告最终数据。** 截至上一交易日收盘，股价年内翻了一番多","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","SKYE","BK4139","MOBI"],"gpt_icon":0},{"id":"2457904567","title":"彭斯凯汽车集团公司:摩根大通将目标价上调至140美元而非135美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457904567","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457904567?lang=zh_cn&edition=full","pubTime":"2024-08-06 19:51","pubTimestamp":1722945097,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MOBI"],"gpt_icon":0},{"id":"2442843715","title":"更新版 1-斯凯生物科学公司中期研究失败，将停止眼病药物开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2442843715","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442843715?lang=zh_cn&edition=full","pubTime":"2024-06-10 19:37","pubTimestamp":1718019473,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (第2至第4段增加了细节)    路透6月10日 - Skye Bioscience   周一表示，由于其实验性眼病治疗药物未能达到中期研究的主要目标，该公司将停止开发该药物，导致其股价 下跌41%。该公司称，SBI-100眼药水未能按预期降低原发性开角型青光眼患者的眼压。     在这种青光眼中，眼液不能正常排出，导致眼压逐渐升高。     斯凯公司表示，它打算停止与该疗法相关的临床开发和支出，将所有临床开发资源用于肥胖症药物项目，从而将其经营期限延长至2027年。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SKYE","MOBI"],"gpt_icon":0},{"id":"2442843666","title":"BUZZ-斯凯生物科学公司因放弃眼病治疗开发而下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2442843666","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442843666?lang=zh_cn&edition=full","pubTime":"2024-06-10 19:27","pubTimestamp":1718018829,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    6月10日 - ** 药物开发商Skye Bioscience   股价盘前下跌45.2%至6美元 ** 该公司表示， (link)，在一项中期研究失败后，它打算停止开发实验性眼病治疗药物。 ** 该公司名为SBI-100的实验性疗法正在接受治疗眼压过高的测试，但未能达到降低眼压的主要研究目标。 ** 截至上次收盘，该公司股价年累计涨幅超过 302","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MOBI","SKYE","BK4139","BUZZ"],"gpt_icon":0},{"id":"2442487468","title":"斯凯生物科学公司将停止开发眼病治疗药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2442487468","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442487468?lang=zh_cn&edition=full","pubTime":"2024-06-10 19:15","pubTimestamp":1718018146,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透6月10日 - Skye Bioscience   周一表示，在一项中期研究失败后，该公司打算停止开发实验性眼病治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SKYE","MOBI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sky-mobi.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"杭州斯凯网络科技有限公司根据开曼群岛法律于2007年4月20日成立为有限公司，公司透过其附属公司主要从事移动应用平台嵌入在手机上的操作提供在中国人民共和国移动应用商店和移动服务。","exchange":"NASDAQ","name":"斯凯","nameEN":"Sky-mobi"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"斯凯(MOBI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供斯凯(MOBI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"斯凯,MOBI,斯凯股票,斯凯股票老虎,斯凯股票老虎国际,斯凯行情,斯凯股票行情,斯凯股价,斯凯股市,斯凯股票价格,斯凯股票交易,斯凯股票购买,斯凯股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"斯凯(MOBI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供斯凯(MOBI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}